Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as "a Kafkaesque nightmare" with over-officious bureaucracy putting pointless hurdles in patients' way
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields